SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Fuse Medical, Inc. – ‘10-K’ for 12/31/18 – ‘EX-10.28’

On:  Thursday, 3/21/19, at 5:13pm ET   ·   For:  12/31/18   ·   Accession #:  1564590-19-8819   ·   File #:  0-10093

Previous ‘10-K’:  ‘10-K/A’ on 9/21/18 for 12/31/17   ·   Next:  ‘10-K’ on 3/30/20 for 12/31/19   ·   Latest:  ‘10-K’ on 4/14/23 for 12/31/22   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/21/19  Fuse Medical, Inc.                10-K       12/31/18  120:42M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    861K 
 4: EX-10.14    Material Contract                                   HTML    285K 
 5: EX-10.15    Material Contract                                   HTML   1.08M 
 6: EX-10.16    Material Contract                                   HTML    253K 
 7: EX-10.17    Material Contract                                   HTML     73K 
 8: EX-10.18    Material Contract                                   HTML    278K 
 9: EX-10.19    Material Contract                                   HTML     35K 
10: EX-10.20    Material Contract                                   HTML    255K 
11: EX-10.21    Material Contract                                   HTML     96K 
12: EX-10.22    Material Contract                                   HTML     70K 
13: EX-10.23    Material Contract                                   HTML     45K 
14: EX-10.24    Material Contract                                   HTML    119K 
15: EX-10.25    Material Contract                                   HTML     95K 
16: EX-10.26    Material Contract                                   HTML    133K 
17: EX-10.27    Material Contract                                   HTML    167K 
18: EX-10.28    Material Contract                                   HTML     96K 
19: EX-10.29    Material Contract                                   HTML    101K 
20: EX-10.30    Material Contract                                   HTML     46K 
21: EX-10.31    Material Contract                                   HTML     91K 
22: EX-10.32    Material Contract                                   HTML     99K 
23: EX-10.33    Material Contract                                   HTML    122K 
24: EX-10.34    Material Contract                                   HTML    121K 
25: EX-10.35    Material Contract                                   HTML    151K 
26: EX-10.36    Material Contract                                   HTML     45K 
27: EX-10.37    Material Contract                                   HTML     49K 
28: EX-10.38    Material Contract                                   HTML     40K 
29: EX-10.39    Material Contract                                   HTML     95K 
 2: EX-10.4     Material Contract                                   HTML     56K 
30: EX-10.40    Material Contract                                   HTML     97K 
31: EX-10.41    Material Contract                                   HTML     95K 
32: EX-10.42    Material Contract                                   HTML     58K 
33: EX-10.43    Material Contract                                   HTML    112K 
34: EX-10.44    Material Contract                                   HTML    125K 
35: EX-10.45    Material Contract                                   HTML    120K 
36: EX-10.46    Material Contract                                   HTML    111K 
37: EX-10.47    Material Contract                                   HTML    110K 
38: EX-10.48    Material Contract                                   HTML    121K 
39: EX-10.49    Material Contract                                   HTML     69K 
 3: EX-10.5     Material Contract                                   HTML     33K 
40: EX-10.50    Material Contract                                   HTML    115K 
41: EX-10.51    Material Contract                                   HTML    109K 
42: EX-10.52    Material Contract                                   HTML    122K 
43: EX-10.53    Material Contract                                   HTML    122K 
44: EX-10.54    Material Contract                                   HTML     47K 
45: EX-10.55    Material Contract                                   HTML     98K 
46: EX-10.56    Material Contract                                   HTML    121K 
47: EX-10.57    Material Contract                                   HTML    121K 
48: EX-10.58    Material Contract                                   HTML    122K 
49: EX-10.59    Material Contract                                   HTML    121K 
50: EX-10.60    Material Contract                                   HTML    122K 
51: EX-10.61    Material Contract                                   HTML    121K 
52: EX-10.62    Material Contract                                   HTML    121K 
53: EX-10.63    Material Contract                                   HTML    113K 
54: EX-10.64    Material Contract                                   HTML     55K 
55: EX-21.1     Subsidiaries List                                   HTML     29K 
56: EX-23.1     Consent of Experts or Counsel                       HTML     30K 
57: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
58: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
59: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
66: R1          Document and Entity Information                     HTML     65K 
67: R2          Consolidated Balance Sheets                         HTML    109K 
68: R3          Consolidated Balance Sheets (Parenthetical)         HTML     53K 
69: R4          Consolidated Statements of Operations               HTML     92K 
70: R5          Consolidated Statement of Changes in Stockholders'  HTML     73K 
                Equity (Deficit)                                                 
71: R6          Consolidated Statements of Cash Flows               HTML    125K 
72: R7          Nature of Operations                                HTML     43K 
73: R8          Significant Accounting Policies                     HTML     79K 
74: R9          Maxim Acquisition                                   HTML     81K 
75: R10         CPM Acquisition                                     HTML     36K 
76: R11         Property and Equipment                              HTML     56K 
77: R12         Revolving Line of Credit                            HTML     43K 
78: R13         Notes Payable - Related Parties                     HTML     33K 
79: R14         Commitments and Contingencies                       HTML     49K 
80: R15         Stockholders' Equity                                HTML    151K 
81: R16         Income Taxes                                        HTML    160K 
82: R17         Concentrations                                      HTML     70K 
83: R18         Related Party Transactions                          HTML     74K 
84: R19         Subsequent Events                                   HTML     34K 
85: R20         Significant Accounting Policies (Policies)          HTML    144K 
86: R21         Significant Accounting Policies (Tables)            HTML     37K 
87: R22         Maxim Acquisition (Tables)                          HTML     75K 
88: R23         Property and Equipment (Tables)                     HTML     56K 
89: R24         Commitments and Contingencies (Tables)              HTML     46K 
90: R25         Stockholders' Equity (Tables)                       HTML    148K 
91: R26         Income Taxes (Tables)                               HTML    162K 
92: R27         Concentrations (Tables)                             HTML     77K 
93: R28         Nature of Operations (Details Narrative)            HTML     47K 
94: R29         Significant Accounting Policies (Details            HTML     83K 
                Narrative)                                                       
95: R30         Significant Accounting Policies - Estimated Useful  HTML     39K 
                Lives of Assets (Details)                                        
96: R31         Maxim Acquisition (Details Narrative)               HTML     51K 
97: R32         Maxim Acquisition - Schedule of Components of       HTML     42K 
                Aggregate Purchase Price (Details)                               
98: R33         Maxim Acquisition - Summary of Assets Acquired and  HTML     79K 
                Liabilities Assumed (Details)                                    
99: R34         CPM Acquisition (Details Narrative)                 HTML     62K 
100: R35         Property and Equipment (Details)                    HTML     46K  
101: R36         Property and Equipment (Details Narrative)          HTML     32K  
102: R37         Revolving Line of Credit (Details Narrative)        HTML     83K  
103: R38         Notes Payable - Related Parties (Details            HTML     51K  
                Narrative)                                                       
104: R39         Commitments and Contingencies (Details Narrative)   HTML     58K  
105: R40         Commitments and Contingencies - Summary of          HTML     41K  
                Operating Leases (Details)                                       
106: R41         Stockholders' Equity - Summary of Compensation      HTML     43K  
                Expense for Stock Options Granted to Board                       
                Members, Employees And Marketing Representatives                 
                (Details)                                                        
107: R42         Stockholders' Equity (Details Narrative)            HTML     49K  
108: R43         Stockholders' Equity - Summary of Stock Option      HTML     70K  
                Activity (Details)                                               
109: R44         Stockholders' Equity - Summary of Restricted Stock  HTML     62K  
                Awards Activity (Details)                                        
110: R45         Income Taxes - Components of Income Tax Expense     HTML     52K  
                (Benefit) (Details)                                              
111: R46         Income Taxes - Significant Components of Deferred   HTML     73K  
                Income Tax Assets and Liabilities (Details)                      
112: R47         Income Taxes (Details Narrative)                    HTML     42K  
113: R48         Income Taxes - Reconciliation of Income Tax         HTML     50K  
                Computed at U.S. Statutory Rate to Effective                     
                Income Tax Rate (Details)                                        
114: R49         Concentrations - Significant Customers with         HTML     38K  
                Individual Percentage of Total Revenues Equaling                 
                Ten Percent (10%) or Greater (Details)                           
115: R50         Concentrations - Significant Customers with         HTML     38K  
                Concentration of Accounts Receivable Representing                
                Ten Percent (10%) or Greater of Accounts                         
                Receivable (Details)                                             
116: R51         Concentrations - Significant Suppliers Represented  HTML     40K  
                Ten Percent (10%) or Greater of Goods Purchased                  
                (Details)                                                        
117: R52         Related Party Transactions (Details Narrative)      HTML    133K  
119: XML         IDEA XML File -- Filing Summary                      XML    129K  
118: EXCEL       IDEA Workbook of Financial Reports                  XLSX     75K  
60: EX-101.INS  XBRL Instance -- fzmd-20181231                       XML   1.55M 
62: EX-101.CAL  XBRL Calculations -- fzmd-20181231_cal               XML    169K 
63: EX-101.DEF  XBRL Definitions -- fzmd-20181231_def                XML    521K 
64: EX-101.LAB  XBRL Labels -- fzmd-20181231_lab                     XML   1.12M 
65: EX-101.PRE  XBRL Presentations -- fzmd-20181231_pre              XML    846K 
61: EX-101.SCH  XBRL Schema -- fzmd-20181231                         XSD    171K 
120: ZIP         XBRL Zipped Folder -- 0001564590-19-008819-xbrl      Zip    137K  


‘EX-10.28’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

EXHIBIT 10.28

FH Ortho

Distributor Agreement

DISTRIBUTOR
AGREEMENT

This Agreement is entered into to be effective as of January 1st, 2016 by and between FH Ortho, Inc., 4118 N. Nashville Avenue, Chicago, IL 60634 (the "Company") and CPM Medical Consultants, LLC, 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 ("Distributor").

RECITALS:

A.The Company and Distributor desire to establish a relationship in which the Company will sell and Distributor will purchase and resell the Company's products specified herein to customers located within the territory specified herein.

B.The Company and Distributor seek to assure a thorough understanding of the obligations assumed by each.

AGREEMENT:

In consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1.  Exclusive Distributor.

a.  Appointment as Distributor. Subject to the terms and conditions of this Agreement, the Company hereby grants Distributor the exclusive right to purchase the products listed on Exhibit A attached hereto, as may be amended from time to time by written agreement of the parties to add additional products (the "Products") for resale to customers located in the geographical territory described on Exhibit B attached hereto (the "Territory") for use within the field of orthopedic I sport surgery (the "Field"). The Company shall have the right to discontinue any of the Products, to make Product improvements and to materially change the design of the Products. The Company agrees to provide Distributor with reasonable advance notice of such discontinuances, improvements or changes in design.

b.  Exclusiveness. The parties agree that the "exclusive" nature of the foregoing appointment prohibits the Company from itself selling the Products in the EXCLUSIVE Territory for use within the Field and from granting any third party the right to sell the Products in the EXCLUSIVE Territory for use within the Field. Expansion of additional and EXCLUSIVE territory is based upon mutual discussion and agreement.

c.  Non-Exclusiveness. In the State of Texas and Louisiana there are non-exclusive areas where the company may sell product through itself or other third party entities. Notification by the

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

Company to the Agent will be provided prior to such selling arrangements being put in place. These non-exclusive areas are areas where minimal or no sales have been recorded for the past YEAR.

d.  Sales Outside Distributor's Assigned Territory. Distributor agrees not to market, promote, sell or deliver, directly or indirectly, any of the Products outside of the Territory without written consent from the Company. Distributor shall direct to the Company all orders and inquires it receives concerning the Products from parties outside of the Territory. Distributor shall not be entitled to any compensation should a sale result to a party outside of the Territory as a result of any inquiries the Distributor directs to the Company.

e.  Leads. The Company agrees to forward to Distributor any orders or requests for information it may receive regarding the Products from a person who is located within the Territory.

2.  Purchase of Products.

a.  Placement of Orders. Distributor shall order the Products by delivering a written purchase order to the Company by mail, email or fax. Orders shall be binding upon the Company only upon its written acceptance or upon shipment of the Products.

b.  Terms and Conditions. This Agreement sets forth the exclusive contract terms between the parties and shall apply to all orders for the Products. The Company rejects any terms in any order forms submitted by Distributor or other Distributor documents which are different from or additional to the provisions hereof and no such terms shall be binding upon the Company notwithstanding the Company's acceptance and shipment of Products ordered in Distributor's orders containing such terms.

3.  Prices and Payment.

a.  Prices. The prices for the Products payable by Distributor to the Company shall be the Company's standard distributor list prices that are in effect at the time Distributor submits its order to the Company. The current standard distributor price list of the Products is attached as Exhibit C to this Agreement. . The Company shall have the right to change the standard distributor price list not more than once every 12-month period. The Company shall provide Distributor at least 30 days written notice in advance of the effective date of the new price list. The Company will honor the previous pricing for orders received prior to the effective date of the new price list provided that the orders are for not more than a 60 days supply of Products based on the Distributor's prior 6 months Product purchases. The company will not increase prices more than 3% per year.

b.  Taxes: Shipping Costs. All prices are quoted F.O.B. the Company's Chicago, Illinois facility. Distributor shall pay any and all taxes, fees, duties or other governmental charges and for any and all shipment and shipping insurance costs

c.  Payment. Distributor shall make all payments in U.S. dollars to the Company's Chicago, Illinois facility by the thirtieth (30th) day after the date of the Company's invoice. If payment is received within 10 days of invoice, a 2% (two) discount will be applied to that invoice not including shipping charges. These payment terms will not apply to Distributor until the Company

2

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

has received the credit information requested from Distributor, which may include financial statements of the Distributor, bank references, trade references and other similar information as requested by the Company, that provides the Company with reasonable assurance of payment. Distributor shall provide additional credit information from time to time as requested by the Company to verify its creditworthiness. The Company reserves the right, without liability to Distributor, to refuse to ship additional Products and to otherwise suspend performance under this Agreement if at any time (a) the Distributor fails to provide such requested information to provide the Company reasonable assurance of payment or (b) the Distributor is delinquent in payment of Products previously shipped.

d.  Late Payment Fee/Collection Costs. Any amounts not paid by Distributor when due will be subject to a late payment fee computed daily at a rate equal one percent (1.0%) per month or at the highest rate permitted under applicable usury law, whichever is lower. In addition, Distributor shall be liable to the Company for all costs incurred by the Company in its collection of any amounts owing by Distributor which are not paid when due, including reasonable attorneys' fees and expenses, regardless whether an actual lawsuit is commenced.

4.  Delivery. Shipment and Inspection.

a.  Delivery and Shipment. The Company shall deliver the Products to the carrier specified by Distributor in its purchase order at dock of the Company's Chicago, Illinois facility.

b.  Inspection. Distributor shall inspect all Products immediately after arrival and shall notify the Company in writing within ten (10) days after receipt of any shortages, nonconformance with the purchase order or any other failure under this Agreement. Any shortages, or other failures under this Agreement not reported within such ten (10) Day period shall be forever waived by Distributor.

c.  Delivery Dates. All delivery dates for the Products are best estimates based upon prevailing conditions when given and the Company shall not be in breach of this Agreement or otherwise liable to Distributor if it fails to meet any delivery dates.

d.  Force Majeure. The Company shall not be liable to Distributor for any delay or failure of delivery or other performance caused in whole or in part by any contingency beyond the Company's reasonable control, including without limitation, acts of God, acts of any government or any agency or subdivision thereof, any acts of terrorism, or shortage or inability to secure labor, fuel, energy, raw materials, supplies or machinery at reasonable prices from regular Sources. The Company shall have the right to allocate Products between its various distributors and customers during a period of shortages without incurring any liability whatsoever to Distributor for those products supplied by Company on consignment basis. All products having been sold to Distributor and paid for by Distributor shall be void of the aforementioned shortage allocation plan.

5.  Minimum Purchase Requirement.

a.  Initial Requirements. Distributor agrees to order, accept delivery of and make payment in full for the number of Products set forth on Exhibit D attached hereto during the time period set forth on such Exhibit (the "Initial Minimum Purchase Requirements"). If Distributor fails to meet the Initial Minimum Sales Requirement or any Minimum Purchase Requirement established for

3

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

any future period during the term of this Agreement as provided in subparagraph b below, the Company shall have the right to terminate this Agreement by providing Distributor thirty (30) days notice of termination. If the Company chooses not to terminate this Agreement due to the failure of Distributor to achieve the Minimum Purchase Requirements for a given period, the shortfall will be added to the Minimum Purchase Requirement for the subsequent period.

b.  Establishment of Future Requirements. The parties agree to meet and negotiate in good faith to establish Minimum Purchase Requirements for any future period during the term of this Agreement that is not established in Exhibit D at the time of execution of this Agreement. If the parties are unable to agree on Minimum Purchase Requirements for any future period of this Agreement at least thirty (30) days prior to the expiration of the current Minimum Purchase Requirement period, either party shall have the right to terminate this Agreement by delivery of sixty (60) days written notice to the other party.

c.  Product Expiration Guarantee. Company agrees to sell to Distributor only product with a minimum of 3-year term to expiration. If product expiration is less than 3 years at the time of sale by Company to Distributor, Distributor has the right to exchange product at no cost or liability within I year of the initial acquisition.

d.  Resterilization of any metal implant will be charged to Distributor at the Company's cost to do such.

6.  Company's Duties. The Company agrees to perform the following duties at its own expense:

a.  Product Literature. The Company shall furnish Distributor reasonable quantities of sales literature and other sales material developed by the Company for use in the sale and promotion of the Products. The Company reserves the right to charge a reasonable purchase price on specific sales material and excessive quantities of sales materials, as determined by the Company from time to time.

b.  Product Information Seminars. The Company shall provide, from time to time, seminars in the proper application and use of the Products for Distributor and its employees or Agents.

The parties shall mutually agree upon the location of such seminars. The cost of conducting such seminars shall be paid for by the Company and all other costs associated therewith, including travel, food and lodging expenses, shall be paid by Distributor.

c.  Limited Warranty.

(i)  Limited Warranty. The Company warrants to Distributor that the Products will be free from defects in materials and workmanship at the time of shipment of the Products to Distributor (the "Limited Warranty"). The Company's SOLE OBLIGATION and Distributor's SOLE REMEDY in the event of a defect covered by this warranty will be, at Company's option, to (a) replace the defective Product, or (b) refund to Distributor the purchase price paid by Distributor for such defective Product.

(ii)  Warranty Procedure. In order to recover under this Limited Warranty, Distributor must contact the Company and receive written authorization for return of any

4

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

Product it alleges is defective. Distributor must return the alleged defective Product in accordance with the Company's RMA procedures. If the Company determines that the Product is defect and elects to replace the defective Product, all freight and insurance costs for shipping the replacement Product shall be paid by the Company. ANY

UNAUTHORIZED SHIPMENT OR SHIPMENT CONTRARY TO COMPANY'S INSTRUCTIONS WILL VOID THIS LIMITED WARRANTY. The Company will solely determine final disposition of any warranty claim.

(iii)  Limited Warranty Exclusions. THIS LIMITED WARRANTY DOES NOT COVER ANY LOSS CAUSED BY CARELESS HANDLING OF THE PRODUCT. THIS LIMITED WARRANTY ALSO SHALL NOT APPLY TO ANY PRODUCT WHICH HAS BEEN DAMAGED IN TRANSIT, ABUSED, ALTERED, MODIFIED, USED IN A MANNER NOT ORIGINALLY INTENDED, OR USED IN A MANNER NOT CONSISTENT WITH THE PRODUCT INSTRUCTIONS.

(iv)  Disclaimers. THE LIMITED WARRANTY SET FORTH ABOVE IS IN LIEU OF ALL WARRANTIES EXPRESS, IMPLIED OR STATUTORY, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF   MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT, AND WARRANTIES ARISING FROM COURSE OF DEALING, USAGE OF TRADE OR OTHERWISE.

(v)  Limited Remedies. THE REMEDIES SET FORTH IN THIS LIMITED WARRANTY ARE THE ONLY REMEDIES AVAILABLE TO DISTRIBUTOR OR ANY PERSON CLAIMING THROUGH DISTRIBUTOR FOR BREACH OF WARRANTY. COMPANY SHALL NOT HAVE ANY LIABILITY TO ANY PERSON FOR INCIDENTAL, CONSEQUENTIAL, INDIRECT OR SPECIAL DAMAGES OF ANY DESCRIPTION, WHETHER ARISING OUT OF WARRANTY (INCLUDING ANY IMPLIED WARRANTIES) OR ANY OTHER CONTRACT, NEGLIGENCE OR OTHER TORT OR OTHERWISE.

d.  Insurance. The Company shall maintain products liability insurance coverage with respect to design, development and manufacture of the Products in amounts no less than One Million Dollars ($1,000,000) per incident with a maximum of Two Million Dollars ($2,000,000) per year, and shall furnish Distributor with written evidence of such coverage upon request.

7.  Distributor's Duties. Distributor agrees to perform reasonable best efforts in the following duties at its own expense:

a.  Promotion of Products. Distributor agrees to devote its best efforts to promote the sale of and stimulate interest in the Products in the Territory. Without limiting the generality of the foregoing, Distributor shall investigate and follow-up on any and all inquiries from potential customers within the Territory, however generated, and shall promptly handle all correspondence and personal contacts as required with such potential customers in pursuing such leads. Distributor will be expected to exhibit at trade shows, train surgeon customers in the use of the Products.

b.  Personnel. Distributor will hire and maintain personnel with sufficient technical expertise and knowledge of the Products to train customers in the use of the Products. Distributor

5

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

shall be solely responsible for hiring, training, compensation, termination and all other matters relating to any persons, companies or corporations employed by Distributor for any reason whatsoever.

c.  Marketing Plan. Distributor agrees to submit to the Company, for its approval, a marketing plan and to submit revisions to such plan to the Company for its approval every sixe months during the term of this Agreement. Distributor agrees to carry our its marketing efforts in   substantial compliance with the marketing plan as approved by the Company. The initial marketing plan, as approved by the Company, is set forth on Exhibit E attached hereto.

d.  Inventory. Distributor will at all times maintain an inventory of the Products sufficient to meet reasonably anticipated orders in the Territory.

e.  Altering Company's Products, Instruments. Literature or Packaging. Distributor agrees not to alter, in any way, the Company's Products, the Product packaging or labeling or Product literature without the express, prior written approval of the Company. All promotional or marketing literature or documentation relating to the Products prepared by Distributor shall be subject to the prior written approval of the Company and may not be used without such approval having first been obtained.

f.  Reports. Distributor agrees to submit to the Company all reports reasonably requested by the Company, including, without limitation, inventory reports, which will reflect beginning and ending inventory levels of all Products.

g.  Product Warranties. Distributor shall not make any warranty or representation as to the Products or promise any remedies or return policies relating thereto which is different from or in addition to the warranties, representations, remedies and return policies contained in the Company's Written Product literature, Product packaging inserts and/or online policies, as amended from time to time by the Company.

h.  Permits and Licenses. Distributor shall obtain all necessary governmental and other permits and licenses which may be required for Distributor to promote and sell the Products in the Territory

i.  Laws and Regulations. Distributor shall conform to all applicable laws and regulations and to the highest business ethics in performing its obligations in accordance with the terms of this Agreement.

j.  Competitive Products. During the term of this Agreement, Distributor agrees not to sell, handle, promote or be involved, directly or indirectly, in the offering for sale, promotion or manufacture of any product, which competes with the Products in the Territory without the Company's prior written approval.

k.  Doctor Training. Distributor will ensure that each doctor/surgeon using the Products is properly trained in its use. If requested by the Company, Distributor shall confirm such training through use of a signed surgeon training agreement or such other confirmation method as requested by the Company.

6

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

l.  Incident Report. Distributor shall advise the Company of any incident of which Distributor becomes aware that involves or may involve the malfunction of the Product. Notice shall be as soon as possible and in no event later than five (5) business days from the date upon which Distributor becomes aware of such incident.

m.  Customer Complaints and Service Requirements. Distributor shall use its reasonable and best efforts to resolve all customer complaints relating to the quality of services provided by Distributor in conjunction with the Products in a manner consistent with the Company's commitment for exceptional customer service. Distributor agrees to report to the Company any customer complaints.

n.  Product Tracking. Distributor shall maintain a system in place to track each Product. Such system will, at a minimum, be able to identify a Product to its final destination and shall have recall procedures in place, which facilitate locating each Product, shipped in the event customer notifications or product modifications are required. Such reports shall include at least the following:

(i)  Customer name and purchase order number

(ii)  Address where products were delivered

(iii)  Date of sale

(iv)  Lot or serial number (if applicable)

(v)  Company product number

(vi)  Quantities sold

Upon termination or expiration of this Agreement, Distributor shall, at the Company's request, deliver all records relating to the location of Products to the Company.

o.  o.Recall. If Company, any governmental agency or other proper authority issues a product recall of any of the Products, Distributor agrees to fully cooperate with Company (i) in promptly contacting any purchasers which Company desires to be contacted during the course of any such recall, (ii) in promptly communicating to such purchasers such information or instructions as Company may desire be transmitted to such purchasers, (iii) in obtaining the removal of all such recalled Products from Distributor's inventory and the inventory of its customers and (iv) in disposing of such recalled Product as Company so directs. Company agrees to reimburse Distributor for all direct out-of-pocket costs and expenses actually incurred by Distributor as a result of securing the removal of and disposing of such recalled Products as requested by Company.

p.  Insurance. Distributor shall carry general liability, products liability and property damage insurance covering all hazards, injuries, losses or damages caused by or arising out of the possession or sale of the Products by Distributor in such amounts and with such reputable insurance companies as the Company shall reasonably approve. Distributor shall provide the Company with insurance certificates evidencing its insurance coverage.

7

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

q.  Ownership. Distributor represents and warrants that it has accurately disclosed to the Company its ownership structure and that no person or entity that is a competitor of the Company owns ten percent or more of the Distributor. Distributor agrees to notify the Company in writing of any change in its ownership within fifteen (15) days of the effective date of such change.

8.  Trademarks. Patents and Use of Name. Distributor acknowledges that it has no right, title or interest in any of the Products, nor in any patents, patent applications, trade secrets, trademarks, trade names, service marks, knowhow or copyrights applicable thereto. Distributor recognizes the Company's exclusive ownership and right, title and interest in and to all of the Company's trademarks and trade names (whether or not registered in the Territory) used in connection with the Products. Distributor acknowledges that the Company is not by this Agreement granting any right or license whatsoever, by implication, estoppel or otherwise, to Distributor to utilize any patents, patent applications, trade secrets, trademarks, trade names, service marks, knowhow or copyrights which the Company may have or may secure in the future relating to any of the Products. Distributor agrees not to use the Company's name, any other similar name or any other trademark of the Company except in advertising, pamphlets, letterhead or other media promotion of the Products, which is approved in writing by the Company prior to its use or dissemination. Distributor may not use the Company s name or any of the Company's trademarks in its corporate or business name, or in any other manner, which the Company deems adverse to its interests.

a.  Custom Device Development and Intellectual Property Ownership. Any intellectual property generated via the specific development of a specific custom product on behalf of a specific customer or by the Distributor will be shared between the company, the costumer and the distributor as follows 50% for the company developing, 25% for the distributor and 25% for the customer (surgeon).

9.  Confidential Information.

a.  Definition. "Confidential Information" means any information or compilation of information which is proprietary to the Company and which relates to its existing or reasonably foreseeable business, including, but not limited to, trade secrets and information contained in or relating to product designs, manufacturing methods, processes, techniques, tooling, sales techniques, marketing plans or proposals, existing or potential customer lists and all other customer information. Information shall be treated as Confidential Information irrespective of its source and all information, which the Company identifies as being "confidential" or "trade secret" shall be presumed to be Confidential Information. Confidential Information shall not include information which: (I) was in the public domain at the time it was disclosed; (ii) enters the public domain other than by breach of this Agreement; (iii) is known to the receiving party at the time of its disclosure; (iv) is disclosed to the receiving party without restriction by a third party who has the right to do so; or (v) is developed by the receiving party independently of any information disclosed hereunder.

b.  Nondisclosure. During the term of this Agreement and at all times thereafter , Distributor agrees to hold in strictest confidence and to never disclose, furnish, communicate, make accessible to any person or use in any way for Distributor's own or another's benefit any Confidential Information or permit the same to be used in competition with the Company. Distributor agrees to

8

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

refrain from such acts and omissions, which would reduce the value of the Confidential Information to the Company.

10.  Independent Contractor.

a.  Relationship. Distributor is and shall remain an independent contractor and is not and shall not be deemed to be an employee, joint venture, partner or franchisee of the Company for any purpose whatsoever. Accordingly, Distributor shall be exclusively responsible for the manner in which it performs its duties under this Agreement and for the profitability or lack thereof of its activities under this Agreement. All financial obligations associated with Distributor's business is the sole responsibility of Distributor. Distributor does not have, and shall not represent itself as having, any right or authority to obligate or bind the Company in any manner whatsoever.

b.  Employee Obligations. Distributor shall be solely responsible to its own employees for any compensation due them and for compliance with all applicable laws with respect to workmen's compensation, withholding taxes, unemployment compensation, social security payments, and any other charges against compensation imposed by any governmental authority as to Distributor's own employees.

11.  Indemnification. Distributor and Company shall indemnify each other and hold each other harmless from any and all loss, damage, liability, cost or expense (including reasonable attorneys' fees and expenses) which either may incur or suffer as a result of any claim of any kind whatsoever arising out of (a) any act or omission by Distributor or any of its agents or employees which violates this Agreement; (b) any claim for breach of representation based upon any representation given or purportedly given by Distributor, its agents or employees which is different from or in addition to written representations contained in the Company's Product literature, as amended from time to time; (c) any third party claim for personal injury, damage, economic loss or other damage, caused by or arising out of the use of the Products proximately caused by or resulting from the negligence of Distributor, its agents or employees; (d) any claim or demand arising from the employment or engagement by Distributor of any person or entity and (e) the failure of Distributor to pay amounts in respect of taxes which the Distributor is required to pay under this Agreement or in relation to the resale of the Products.

12.  Term. This Agreement shall remain in force for a period of three (3) years commencing on the Effective Date, unless sooner terminated under the provisions of Section 13 below. This Agreement may only be renewed after the expiration of its original term by the mutual written agreement of both parties hereto.

13.  Termination. This Agreement may be terminated prior to the expiration of its term pursuant to any of the following provisions:

a.  Failure to Meet Minimum Purchase Requirements. The Company may terminate this Agreement in accordance with the provisions of Section 5(a) if Distributor fails to meet any Minimum Purchase Requirement.

b.  Failure to meet Future Minimum Purchase Requirements.  Either party shall have the right to terminate this Agreement with notice in accordance with the provisions of Section 5(b) if the parties are unable to agree on future Minimum Purchase Requirements.

9

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

c.  Breach of Agreement. Either party may terminate this Agreement by delivery of written notice to the other party ifthe other party breaches any ofthe terms and conditions of this Agreement; provided, however, if the breach is curable such notice shall not be effective unless and until such breach remains uncured for a period of thirty (30) days after delivery of such notice.

d.  Change in Management. The Company may terminate this Agreement at any time effective upon delivery of written notice to Distributor if the ownership of Distributor should change so that ten percent (10%) or more of the Distributor is owned by a competitor of the Company.

e.  Insolvency. Either party may terminate this Agreement effective immediately upon delivery of written notice to the other party, if the other party (i) ceases to actively conduct its business, (ii) files a voluntary petition for bankruptcy or has filed against it an involuntary petition for bankruptcy, (iii) becomes unable to pay its debts as they become due, (iv) makes a general assignment for the benefit of its creditors or (v) applies for the appointment of a receiver or trustee for substantially all of its property or assets or permits the appointment of any such receiver or trustee who is not discharged within thirty (30) days of such appointment.

f.  Change in Company Ownership.  If a transfer of greater than or equal to 51% equity stake of the Company to any outside party (not related to current shareholder) and if this agreement is terminated for any reason other than distributor not reaching its quotas, distributor wil I be compensated with an indemnity equal to its last 6 months revenue.

14.  Obligations Upon Termination. Following expiration or termination of this Agreement for any reason, the following provisions shall apply:

a.  Return of Samples and Confidential Information. Distributor shall within ten (10) days after request by the Company, return to the Company all sample Products and copies of Product literature and materials and all documents or copies thereof containing any Confidential Information of the Company.

b.  Payment Obligations. Distributor shall promptly pay when due any amounts owing to the Company on orders of the Products accepted by the Company prior to the effective date of expiration or termination.

c.  Repurchase of Product Inventory. The Company shall have the option, exercisable in its sole discretion, to repurchase from Distributor (or arrange to have a distributor of the Company purchase from Distributor) any current, non-damaged Product inventory with preemption date of at least 6 months. Current, non-damaged products with a preemption date of less than one year but more than six months may be purchased back with a 20% restocking charge. The Company shall pay to Distributor the price, which is equal to the lesser of (I) the Distributor's original purchase price or (2) a price, which reflect the condition and marketability of the Products. If the Company chooses to repurchase (or have its other distributor repurchase) the Distributor's product inventory, (I) Distributor shall cease further marketing and distribution of the Products, except to fulfill sales for which it was contractually committed prior to the expiration or termination of this Agreement and (ii) Distributor shall discontinue any and all use of any of the Company's logos, trademarks and trade names and any of the Company's Confidential Information.

10

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

d.  Sale of Non-purchased Inventory. Distributor shall have the right to sell any Products in its inventory which are not repurchased by the Company (or its designated distributor) as provided in subparagraph c above, for a period of one hundred twenty (120) days after the effective date of expiration or termination of this Agreement.

e.  Continued Sales By Company. The sale of Products to Distributor by the Company after expiration or termination of this Agreement shall in no manner constitute or be deemed a renewal or extension of this Agreement nor the appointment, retention or reappointment of Distributor as a distributor of Products in the Territory or el s e w here.

f.  Continuing Obligations. The rights and obligations of parties under Sections 9 —Confidential Information, 1 1 - Indemnification, 13 —Obligations Upon Termination and 15 —General Provisions herein shall survive the expiration and termination ofthis Agreement and shall continue in full force and effect.

15.  General Provisions.

a.  Notices. Any notice required or permitted to be given under this Agreement shall be deemed delivered (I) when received if delivered by hand, (ii) the next business day if placed with a reputable express carrier for delivery during the morning of the following business day, or (iii) three (3) days after depositing in the U.S. mails for delivery by registered or certified mail, return receipt requested, postage prepaid and addressed to the appropriate party at the address set forth on the first page of this Agreement. If either party should change its address for notice purposes, such party shall give written notice of the other party of the new address in the manner set forth above, but any such notice shall not be effective until actually received by the addressee.

b.  Modification and Waiver. No purported amendment, modification or waiver of any provision hereof shall be binding unless set forth in a writing signed by both parties (in the case of amendments and modifications) or by the party to be charged thereby (in the case of waivers). Any waiver shall be limited to the circumstance or event specifically referenced in the written waiver document and shall not be deemed a waiver of any other term of this Agreement or of the same circumstance or event upon any recurrence thereof.

c.  Assignment. Distributor or Company shall not assign, transfer or sell all or any part of its rights or obligations hereunder, by operation of law or otherwise, without the prior written consent of the Company. This Agreement shall be binding upon and inure to the benefit of any successor or assignee.

d.  Severability and Interpretation. In the event that a court of competent jurisdiction holds a provision of this Agreement invalid, the remaining provisions shall nonetheless be enforced in accordance with their terms. Further, in the event that any provision is held to be overbroad as written, such provision shall be deemed amended to narrow its application to the extent necessary to make the provision enforceable according to applicable law and shall be enforced as amended.

e.  LIMITATION OF REMEDY. THE COMPANY SHALL HAVE NO LIABILITY TO DISTRIBUTOR OR ANY OTHER PARTY FOR INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES OF ANY DESCRIPTION, WHETHER ARISING OUT OF

11

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

WARRANTY OR OTHER CONTRACT, NEGLIGENCE OR OTHER TORT, OR OTHERWISE.

f.  Controlling Law. This Agreement shall be governed by, construed and interpreted in accordance with the laws of the State of Illinois, without application of its conflict of laws provisions.

g.  Entire Agreement. This Agreement, together with the Exhibits, constitutes the entire Agreement between the parties and supersedes any and all prior and contemporaneous oral or written understandings between the parties relating to the subject matter hereof.

The parties have executed this Agreement in the manner appropriate to each to be effective the day and year entered on the first page hereof.

FH ORTHOPEDICS, INC.

(The “Company”)

Jim Hook, Managing Director

CPM MEDICAL CONSULT, LCD

("Distributor")

131 1 McLaughlin, CPA

Chief Financial Officer

 

 

 

12

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

Exhibits

A.

Products

B.

Territory

C.

Prices

D.

Minimum Purchase Requirements

 

 

 

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

EXHIBIT A

Products

The Arrow Universal Shoulder Prosthesis

CoLS Classic ACL Reconstruction System

Calcanail Calcaneal Fracture Nail

 

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

EXHIBIT B

Territory

Exclusive:

The following Counties EAST and NORTH of the line, inclusive, in the State of Texas:

Hardeman, Foard. Knox, Haskell, Jones, Taylor, Coleman, Brown, Mills, Lampasas, Coryell, Bell Milani, Robertson, Leon, Houston, Trinity, Angelina, San Augustine and Sabine with the exception of Bowie County (Texarkansas) in the far Northeast corner of the State.

Non-Exclusive:

All of the counties in the State of Texas and Louisiana not noted in the "EXCLUSIVE" territory listed above.

 

 

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

EXHIBIT
C

The attached price list is in effect from the present time until September 30, 2016. A 3% price increase will be implemented on October 1, 2016 and will be in effect for 1 year until October 1, 2017.

2015-16 CPM Medical Consultants, LLC

Effective through September 30’ 2016-GS

V5 CoLS instrument set

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

 

17

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

 

 

18

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

 

19

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

 

20

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

21

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

 

 

22

 


Distribution Agreement FH Orthopedics, Inc — CPM Medical Consultants

EXHIBIT D

The quota for the FY 2015-16 is $807,100.00. The minimum purchase requirements for the same period is 75% of the $807,100 or $605,325. The minimum purchase requirements reflect an 18% increase over the prior year.

 

21/21

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/21/198-K
For Period end:12/31/18
10/1/17
10/1/16
9/30/1610-Q
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/14/23  Fuse Medical, Inc.                10-K       12/31/22   74:8.7M                                   ActiveDisclosure/FA
 3/31/22  Fuse Medical, Inc.                10-K       12/31/21   72:8.6M                                   ActiveDisclosure/FA
 3/31/21  Fuse Medical, Inc.                10-K       12/31/20   72:7.1M                                   ActiveDisclosure/FA
Top
Filing Submission 0001564590-19-008819   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 5, 2:13:45.1am ET